603259 藥明康德
按盤價 
91.100 +0.230 (+0.253%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 18.638 | 16.615 | 18.890 | 20.718 | 14.361 |
| 總資產報酬率 ROA (%) | 13.806 | 12.274 | 13.887 | 14.712 | 10.052 |
| 投入資產回報率 ROIC (%) | 16.171 | 14.389 | 16.074 | 17.209 | 11.686 | 邊際利潤分析 |
| 銷售毛利率 (%) | 46.622 | 41.479 | 41.179 | 37.296 | 36.285 |
| 營業利潤率 (%) | 45.854 | 29.510 | 29.430 | 27.067 | 26.363 |
| 息稅前利潤/營業總收入 (%) | 46.346 | 27.402 | 28.492 | 26.351 | 26.633 |
| 淨利潤/營業總收入 (%) | 37.150 | 24.382 | 24.046 | 22.621 | 22.425 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 77.146 | 103.114 | 98.312 | 89.975 | 71.944 |
| 價值變動淨收益/利潤總額(%) | 27.027 | 6.856 | 1.657 | 9.022 | 20.993 |
| 營業外收支淨額/利潤總額(%) | -0.193 | -0.350 | -0.341 | -0.318 | -0.368 | 償債能力分析 |
| 流動比率 (X) | 2.768 | 2.384 | 2.062 | 1.655 | 1.693 |
| 速動比率 (X) | 2.365 | 2.052 | 1.741 | 1.264 | 1.238 |
| 資產負債率 (%) | 24.453 | 26.443 | 24.640 | 27.460 | 29.695 |
| 帶息債務/全部投入資本 (%) | 11.006 | 10.089 | 9.437 | 11.859 | 11.730 |
| 股東權益/帶息債務 (%) | 787.549 | 861.022 | 914.681 | 705.652 | 701.827 |
| 股東權益/負債合計 (%) | 306.688 | 276.046 | 303.673 | 262.277 | 235.136 |
| 利息保障倍數 (X) | 79.872 | -13.669 | -33.994 | -41.822 | 72.544 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 67.350 | 72.718 | 61.906 | 48.447 | 65.110 |
| 存貨周轉天數 (天) | 101.942 | 79.448 | 78.928 | 84.420 | 105.971 |
| 備註： | 即時報價更新時間為 16/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
